美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
NEXIUM	021153	001	NDA	ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED REL PELLETS;ORAL	EQ 20MG BASE	Yes	No	2001/02/20	2001/02/20	ASTRAZENECA	Prescription
NEXIUM	021153	002	NDA	ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED REL PELLETS;ORAL	EQ 40MG BASE	Yes	Yes	2001/02/20	2001/02/20	ASTRAZENECA	Prescription
NEXIUM IV	021689	001	NDA	ESOMEPRAZOLE SODIUM	INJECTABLE;INTRAVENOUS	EQ 20MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2005/03/31	2005/03/31	ASTRAZENECA	Discontinued
NEXIUM IV	021689	002	NDA	ESOMEPRAZOLE SODIUM	INJECTABLE;INTRAVENOUS	EQ 40MG BASE/VIAL	Yes	Yes	2005/03/31	2005/03/31	ASTRAZENECA	Prescription
NEXIUM	021957	001	NDA	ESOMEPRAZOLE MAGNESIUM	FOR SUSPENSION, DELAYED RELEASE;ORAL	EQ 20MG BASE/PACKET	Yes	No	2006/10/20	2006/10/20	ASTRAZENECA	Prescription
NEXIUM	021957	002	NDA	ESOMEPRAZOLE MAGNESIUM	FOR SUSPENSION, DELAYED RELEASE;ORAL	EQ 40MG BASE/PACKET	Yes	Yes	2006/10/20	2006/10/20	ASTRAZENECA	Prescription
NEXIUM	021957	003	NDA	ESOMEPRAZOLE MAGNESIUM	FOR SUSPENSION, DELAYED RELEASE;ORAL	EQ 2.5MG BASE/PACKET	Yes	No	2006/10/20	2011/12/15	ASTRAZENECA	Prescription
NEXIUM	021957	004	NDA	ESOMEPRAZOLE MAGNESIUM	FOR SUSPENSION, DELAYED RELEASE;ORAL	EQ 5MG BASE/PACKET	Yes	No	2006/10/20	2011/12/15	ASTRAZENECA	Prescription
NEXIUM	022101	001	NDA	ESOMEPRAZOLE MAGNESIUM	FOR SUSPENSION, DELAYED RELEASE;ORAL	EQ 10MG BASE/PACKET	Yes	No	2008/02/27	2008/02/27	ASTRAZENECA	Prescription
NEXIUM 24HR	204655	001	NDA	ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE;ORAL	EQ 20MG BASE	Yes	Yes	2014/03/28	2014/03/28	ASTRAZENECA LP	Over-the-counter
NEXIUM 24HR	207920	001	NDA	ESOMEPRAZOLE MAGNESIUM	TABLET, DELAYED RELEASE;ORAL	EQ 20MG BASE	Yes	Yes	2015/11/23	2015/11/23	ASTRAZENECA LP	Over-the-counter